FY 2025 Financial Results Presentation

from the beginning

FY 2025 Financial Results Presentation

• Table of Contents

1. Summary of FY2025: Key Topics and Future Outlook

• What started as a Dream …has become a Reality

• The Growth and Evolution of PeptiDream

• PeptiDream’s Five Core Therapeutic Areas of Focus

• Exceptional Progress in Expanding Clinical Pipeline in 2025

• FY2025 Summary: Entering a New Phase Driven by Pipeline Value

• Progress in Japan’s Late-Stage Development Pipeline

• Global Partnered High-Value Clinical Programs Ongoing

• In-house RI pipeline triggered by the success of CA9

• PDRadiopharma: Japan’s Leader in Radiopharmaceuticals

• 2. Oral & Injectable Peptide Therapeutics

• Significant Progress in Peptide Therapeutics Clinical Programs

• Steady R&D Progress across Multiple Modalities in Non-RI Areas

• 3. Peptide-Oligo Conjugates

• 4. Peptide-Cytotoxic Conjugates (PCCs)

• 5. Multifunctional Peptide -Conjugates (MPCs)

• Expecting Exceptional Expansion of Clinical Programs to Continue

• Enabling the Next Phase of Growth

• Undertaking Investments for Further Growth

2. FY2025 Consolidated Financial Results and FY2026 Forecasts

• Overview for FY2025 Consolidated Results

• Difference from the Initial Forecast for FY2025 Revenue

• FY2025 Consolidated Balance Sheet

• FY2025 Consolidated Cash Flow

• FY2026 Consolidated Revenue Forecast

• Asset Value Creation Across Five Core Areas

• Activities on Sustainability (ESG)

Appendix

• PeptiDream-Mission, Vision, Values

• The PeptiDream Group

• Expansion of R&D Capabilities

• Pipeline Overview: Radiopharmaceuticals

• Growth Drivers: Radiopharmaceuticals

• Pipeline Overview: Non-Radiopharmaceuticals

• Growth Drivers: Non-Radiopharmaceuticals

• Radiopharmaceuticals: Relevant Market Information

• Non-Radiopharmaceutical: Relevant Market Information

• Major Progress of PeptiDream’s Equity Holdings

• Consolidated/Equity Method Applied Companies

• Core/Non-Core Adjustments (FY2025)

• Leadership Team at PeptiDream

• External Directors at PeptiDream

• Analyst Coverage

• Forward-Looking Statements

Mission of PeptiDreamGroup